Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL): The Best-Of-Breed For Investing?
Eventide Asset Management LLC recently announced the acquisition of new stake in Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL). The institutional investor has increased its shareholding in the Healthcare company by 47.94% to 11.56 million shares with purchase of 3.75 million shares. This fresh investment now brings its stake to 16.34% valued currently at $130.05 million. In addition, […]
Provident Financial Services Inc (NYSE: PFS) Is Getting Increasingly Hard To Ignore
American Century Investment Manag recently announced the acquisition of new stake in Provident Financial Services Inc (NYSE:PFS). The institutional investor has increased its shareholding in the Financial company by 3.14% to 2.26 million shares with purchase of 68856.0 shares. This fresh investment now brings its stake to 2.99% valued currently at $34.42 million. In addition, […]
Better Times Ahead For Analog Devices Inc. (NASDAQ: ADI)?
JPMorgan Investment Management, I has recently announced that it has increased stake in Analog Devices Inc. (NASDAQ:ADI) by 15.40%. After grabbing 16.21 million shares, the institutional investor is now in possession of 2.16 million shares of the Technology Company. The new investment brought the stake of investor firm to 3.27% having worth around $2.97 billion. […]
Look For Institutional Buying In Elanco Animal Health Inc (NYSE: ELAN)
PRIMECAP Management Co. has recently announced that it has increased stake in Elanco Animal Health Inc (NYSE:ELAN) by 2.97%. After grabbing 50.63 million shares, the institutional investor is now in possession of 1.46 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 10.27% having worth around $596.41 million. […]
Eventbrite Inc (NYSE: EB) Not A Good Play Anymore?
The Vanguard Group, Inc. has recently announced that it has increased stake in Eventbrite Inc (NYSE:EB) by 0.50%. After grabbing 7.69 million shares, the institutional investor is now in possession of 38303.0 shares of the Technology Company. The new investment brought the stake of investor firm to 9.05% having worth around $54.2 million. Moreover, American […]
Set Your Sights On Therealreal Inc (NASDAQ: REAL)’S Upside Potential
Woodson Capital Management LP has recently announced that it has increased stake in Therealreal Inc (NASDAQ:REAL) by 2.04%. After grabbing 5.0 million shares, the institutional investor is now in possession of 100000.0 shares of the Consumer Cyclical Company. The new investment brought the stake of investor firm to 4.84% having worth around $11.3 million. Moreover, […]
General Mills, Inc. (NYSE: GIS) Stock In Prove Me State
BlackRock Fund Advisors has recently announced that it has increased stake in General Mills, Inc. (NYSE:GIS) by 2.67%. After grabbing 35.35 million shares, the institutional investor is now in possession of 0.92 million shares of the Consumer Defensive Company. The new investment brought the stake of investor firm to 6.08% having worth around $2.25 billion. […]
Solaris Oilfield Infrastructure Inc (NYSE: SOI) – Not A Clear Buying Opportunity?
The Vanguard Group, Inc. has recently announced that it has increased stake in Solaris Oilfield Infrastructure Inc (NYSE:SOI) by 1.01%. After grabbing 1.66 million shares, the institutional investor is now in possession of 16632.0 shares of the Energy Company. The new investment brought the stake of investor firm to 5.42% having worth around $14.18 million. […]
Is There More Upside Ahead For Cymabay Therapeutics Inc (NASDAQ: CBAY)
BlackRock Fund Advisors has recently announced that it has increased stake in Cymabay Therapeutics Inc (NASDAQ:CBAY) by 5.53%. After grabbing 7.0 million shares, the institutional investor is now in possession of 0.37 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 6.17% having worth around $133.88 million. Moreover, […]
Assessing Whether NovoCure Ltd (NASDAQ: NVCR) Is Over- Or Undervalued
Fidelity Management & Research Co has recently announced that it has increased stake in NovoCure Ltd (NASDAQ:NVCR) by 0.21%. After grabbing 15.89 million shares, the institutional investor is now in possession of 33386.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.87% having worth around $195.0 million. Moreover, […]